Growth inhibitory effects of casein hydrolysates on human cancer cell lines by Phelan, Martha et al.
Growth inhibitory effects of casein hydrolysates on
human cancer cell lines
Martha Phelan1, S. Aisling Aherne1, Dara O’Sullivan2, Richard J. FitzGerald2 and Nora M. O’Brien1*
1Department of Food and Nutritional Sciences, University College Cork, Cork, Ireland
2Department of Life Sciences, University of Limerick, Limerick, Ireland
Received 1 April 2009; accepted for publication 18 November 2009; first published online 7 January 2010
The aim of this study was to investigate the effects of unhydrolysed/intact casein and eight
different sodium casein hydrolysates (a–h) on the viability and growth of human cancer cell
lines. Both human Jurkat T cells and Caco-2 cells were incubated with increasing concentrations
of the test compounds (0.5–10% v/v) for 24 h. Cell viability was assessed using the MTT, lactate
dehydrogenase (LDH) release and Trypan Blue assays. Cell growth was monitored using the
MTT, Trypan Blue and Bromodeoxyuridine (BrdU) proliferation assays. Casein hydrolysates b, c
and f had an inhibitory effect on the viability and growth of both cell lines. The casein
hydrolysates did not negatively affect the membrane integrity of both Jurkat and Caco-2 cells. In
Jurkat cells hydrolysates a and h had an inhibitory effect on DNA synthesis after 24 h, while in
Caco-2 cells DNA synthesis was not affected. In conclusion, we found that the different casein
hydrolysates had cell-specific effects which target particular functions within the cell. Overall,
casein hydrolysates had no effect on membrane integrity while they had varied effects on
mitochondrial activity and DNA synthesis in the different cell lines.
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Epidemiological evidence suggests that people who regu-
larly consume fermented dairy foods have a reduced risk
of developing certain cancers (van’t Veer et al. 1989). Milk
proteins, which have long been known for their nutritional
and technological benefits, have also been shown to pos-
sess bioactive properties in addition to their nutritive value
(Hartmann et al. 2007; Phelan et al. 2009). For instance,
cytochemical studies have provided evidence that milk
protein-derived peptides can affect the viability and
growth of cancer cells (Mac Donald et al. 1994; Hartmann
& Meisel, 2004).
Casein and other milk proteins provide a rich source
of bioactive peptides that have physiological roles in the
human body (Korhonen & Pihlanto, 2006). These peptides
affect the major systems including the cardiovascular, im-
mune, nervous and digestive systems (for review see
Korhonen & Pihlanto, 2006). Furthermore, there is a con-
siderable amount of scientific evidence from both in vitro
and in vivo studies to suggest that bioactive peptides
regulate specific physiological functions. Milk-derived
peptides are inactive within the sequences of the parent
protein, such as casein, but can be released during
gastrointestinal digestion, fermentation and food proces-
sing (Korhonen & Pihlanto-Leppa¨la¨, 2001; FitzGerald &
Meisel, 2003). Unravelling the mechanisms through which
dietary factors alter the gastrointestinal environment to
prevent or promote tumour formation is a major challenge
and may never be completely performed using in vivo
experimentation. However, in vitro models may provide
clues to help us understand these mechanisms (Cameron,
1990).
Although Jing and Kitts (2004) showed that casein does
not affect cellular enzymes, Laparra et al. (2008) reported
that caseinophosphopeptides reduced glutathione (GSH)
concentration and increased GSH-reductase activity in
Caco-2 cells. More recently, we demonstrated that eight
distinct casein hydrolysates may exert specific antioxidant
and immunomodulatory effects on human Jurkat T cells
(Phelan et al. 2009). Furthermore, studies have provided
increasing evidence that food-derived bioactive peptides
modulate the viability (e.g. proliferation, differentiation,
and apoptosis) of different cell types such as Int-407 cells
(Jing & Kitts, 2004), HL-60 cells (Hartmann & Meisel,
2004) and Jurkat T cells (Phelan et al. 2009). Therefore,
the aim of the present study was to further investigate
the effects of sodium caseinate and eight distinct casein
hydrolysates on the viability and growth of both human*For correspondence; e-mail : nob@ucc.ie
Journal of Dairy Research (2010) 77 176–182. f Proprietors of Journal of Dairy Research 2010 176
doi:10.1017/S0022029909990471
Jurkat T cells and intestinal Caco-2 cells. Cell viability was
assessed using the MTT (mitochondrial activity), lactate
dehydrogenase (LDH) release (membrane integrity) and
Trypan Blue (membrane integrity) assays. Cell growth was
monitored using the MTT, Trypan Blue and Bromo-
deoxyuridine (BrdU) proliferation (DNA synthesis) assays.
Hence, these assays give a broad insight into the effects of
the test samples on cell membrane integrity, mitochondrial
activity, and DNA synthesis of different cell lines.
Materials and Methods
Materials
Human Jurkat T cells and human adenocarcinoma Caco-2
cells were purchased from the European Collection of
Animal Cell Cultures (Salisbury,Wiltshire, SP4 0JG, UK).
Foetal bovine serum (FBS) was purchased from Invitro-
gen (Paisley, PA4 9RF, Scotland). Cell culture plastics
were supplied by Cruinn Diagnostics (Greiner Bio-One,
Frickenhausen, Germany). All other cell culture reagents
and chemicals were purchased from Sigma-Aldrich
Chemical Co. (Airton Road, Tallaght, Dublin, Ireland)
unless otherwise stated.
Generation of casein hydrolysates
Sodium caseinate (NaCN, 85.92% w/w protein) was pro-
vided by Arrabawn Co-op Society Ltd., Tipperary, Ireland.
The protein content of the NaCN substrate was determined
using the macro-Kjeldahl method (IDF, 2001), a Kjeldahl
conversion factor of 6.38 was used. NaCN hydrolysates
were generated using different commercially available
food-grade enzyme preparations from mammalian, bac-
terial and plant sources. For hydrolysis with neutral pro-
teinase preparations, aqueous solutions of NaCN ranging
in concentration from 9.3 to 10.6% (w/v) protein were
incubated at 50 8C at pH 7. The pH was maintained con-
stant using a pH stat (Titrino 718, Metrohm, Herisau,
Switzerland) charged with 2 M-NaOH as previously de-
scribed (Flanagan & FitzGerald, 2002). In the case of hy-
drolysis with acid proteinase, the NaCN concentration was
5% (w/v) while the pH was maintained constant at pH 2.4
using 1 M-HCl. Enzyme inactivation was by heat treatment
at 80 8C for 20 min. Hydrolysate samples were stored at
–18 8C prior to subsequent analysis. The reversed-phase
HPLC profile of each hydrolysate has been outlined else-
where (Phelan et al. 2009).
Cell culture
Jurkat cells were grown in RPMI medium supplemented
with 5% (v/v) FBS. Caco-2 cells were grown in DMEM
supplemented with 10% (v/v) FBS and 1% (v/v) non-
essential amino acids. Both cell lines were cultured in an
atmosphere of CO2-air (5 : 95, v/v) at 37 8C and were
maintained in the absence of antibiotics. The casein
hydrolysates were filter sterilised (0.2 mm diameter) and
diluted directly with sterile RPMI medium. Samples a, c, d,
h and NaCN were diluted 1/10 prior to filtration as the
concentrated samples could not pass through the filter
membranes (0.2 and 0.45 mm diameter) undiluted. Control
cultures comprised of cells grown in media only.
Incubation of cells with test compounds
For all experiments, Jurkat cells were seeded at a density
of 2r105 cells/ml and Caco-2 cells were seeded at
3r104 cells/cm2. Jurkat cells were supplemented with in-
creasing concentrations (0.5–10% v/v) of NaCN and its
hydrolysates (a–h) for 24 h. Caco-2 cells were allowed
adhere for 24 h in complete media. After 24 h, the culture
media was removed and replaced with growth medium
containing 2.5% (v/v) FBS, 1% (v/v) NEAA and the test
samples (0.5–10% v/v) for 24 h.
MTT assay
Measurement of mitochondrial activity can be carried out
by assessing the activity of the enzyme mitochondrial re-
ductase (Mosmann, 1983; Ciapetti et al. 1993). Mito-
chondrial activity was determined using the MTT assay
(MTT I proliferation kit, Roche Diagnostics; West Sussex,
RH15 9RY, UK). The assay is based on the conversion of
the yellow tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) to its purple for-
mazan product (Mosmann, 1983). At the time of assay,
10 ml pre-warmed MTT labelling reagent was added to
each well of a 96-well plate and then incubated for a fur-
ther 4 h. Solubilising solution (100 ml) was then added to
all wells and incubated overnight at 37 8C. Absorbance
was measured at 570 nm, with a reference wavelength of
690 nm, using a microplate reader.
LDH Release assay
Release of LDH into the medium is an indication of
compromised membrane integrity (Koh & Choi, 1987),
which was measured using an in vitro LDH release assay
kit (Biogenesis, Dorset, BH17 7DA, UK). At the time
of assay, 100 ml media was collected from all test wells
of a 96-well plate. Substrate mix (100 ml) was added to
each sample and incubated at room temperature for 1 h.
HCl (1 M, 50 ml) was then added to each well and the plate
was centrifuged at 716rg for 5 min. Absorbance was
measured at 492 nm using a microplate reader. LDH re-
lease was expressed as fold difference relative to the
control.
Trypan Blue Exclusion assay
This assay is based on the principle that viable cells will
exclude trypan blue dye, whereas dead or dying cells
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absorb the dye and, thus, appear blue (Aras et al. 2008).
At the time of assay, 1.5 ml Jurkat cells in media was
centrifuged at 100rg for 5 min. The supernatant was re-
moved and the cell pellet was re-suspended in PBS.
Trypan blue (50 ml) was mixed with 50 ml cell suspension
(1 : 1) and incubated at room temperature for 3 min. The
mixture was loaded onto a haemocytometer and cells
were analysed using a microscope.
BrdU Cell proliferation assay
DNA synthesis was assessed using the BrdU incorporation
assay (ELISA kit ; Roche, DE-68305, Mannheim, Germany),
which is based on the incorporation of BrdU into the
newly synthesised DNA, substituting for thymidine during
DNA replication (Motobu et al. 2002). Briefly, at the time
of assay, 10 ml BrdU labelling solution was added to each
well of a 96-well plate and the plates were incubated for
a further 24 h. The cells were denatured and fixed using
Fix/Denat solution for 30 min at 37 8C. Anti-BrdU-POD
was then added to the wells and incubated for a further
120 min at 20 8C. Lastly, 100 ml substrate solution was
added to each well and the plates were incubated at 20 8C
until colour development was sufficient. Twenty-five
microliters of 1 M H2SO4 was added as a stopping solution
to each well and absorbance was measured at 450 nm,
using a microplate reader, with a reference wavelength of
690 nm.
Statistical analysis
Results are presented as mean values±SE. Statistical ana-
lysis was evaluated by one-way ANOVA followed by
Dunnett’s test (GraphPad Prism 4.0, GraphPad Inc, San
Diego, CA, USA). The level of statistical significance was
taken at P<0.05 or P<0.01.
Results
Cell Viability
MTT assay: In our previous study (Phelan et al. 2009) we
mentioned that the viability of Jurkat cells decreased sig-
nificantly following incubation with increasing concentra-
tions of the casein hydrolysates (a–h), with the exception
of hydrolysate e (data not shown). Caco-2 cell viability
significantly (P<0.05) decreased in cells that were sup-
plemented with increasing concentrations of samples b,
c, and f for 24 h (Table 1), although viability did not de-
crease below 65%.
LDH Release assay: The presence of the casein hydro-
lysates did not induce LDH release from Jurkat cells (data
not shown). LDH release significantly (P<0.01) decreased
in Caco-2 cells supplemented with casein hydrolysates
a–h for 24 h (Table 2).
Trypan Blue Exclusion assay: After 24 h incubation,
membrane integrity, as measured by this assay, was not
affected by the presence of NaCN and its hydrolysates in
Jurkat cells (data not shown). There was good correlation
between the Trypan Blue assay and the LDH release as-
say in Jurkat cells, hence membrane integrity was not as-
sessed in Caco-2 cells using the Trypan Blue assay.
Cell growth
MTT assay: There was a significant decrease in the
growth of Jurkat cells supplemented with casein hydro-
lysates a–d, and f for 24 h (Table 3; Phelan et al. 2009).
Growth in Caco-2 cells supplemented with increasing
concentrations of samples a, b, c, and f significantly de-
creased (P<0.05, P<0.01) after 24 h incubation (Table 3).
Table 1. Viability of Caco-2 cells incubated with casein hydrolysates (a–h) and sodium caseinate for 24 h†





a b c d e f g h
Caco-2 cells
0.0 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9 100.0±7.9
0.5 93.2±3.6 105.8±5.5 101.4±8.0 101.4±5.0 81.7±3.5 78.3±4.8 107.5±8.8 108.3±9.7 89.6±11.5
1.3 81.2±6.0 81.8±4.4 92.3±7.9 95.8±5.7 75.7±7.7 71.8±5.7* 103.3±5.9 111.9±6.2 92.7±9.2
2.5 82.5±6.0 4.7±6.5 82.9±6.8 103.1±9.5 68.9±2.2 72.1±5.7* 100.9±1.9 103.6±5.9 74.1±3.1
5.0 74.8±5.1 69.5±7.8* 67.3±5.6* 93.2±9.2 86.8±13.5 71.7±8.1* 103.3±11.2 97.8±7.6 82.5±4.1
10.0 70.6±3.8 70.9±8.2* 67.1±6.5* 86.4±7.4 86.8±8.3 72.9±7.8* 105.8±4.6 103.7±6.2 84.3±5.3
NaCN, sodium caseinate (which was only available at the time when using Caco-2 cells)
† Caco-2 cells (3r104 cells/cm2) were supplemented with increasing concentrations of casein hydrolysates (a–h) and sodium caseinate for 24 h
‡Cell viability was determined by the MTT assay and expressed as a percentage of the control
* P<0.05 compared with control (0% v/v) : one-way ANOVA, Dunnett’s test
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Trypan Blue Exclusion assay: After 24 h, cell density was
not affected by the presence of casein hydrolysates in Jurkat
cells (data not shown). As mentioned earlier, there was
good correlation between the Trypan Blue assay and the
LDH release assay in Jurkat cells; hence, cell density was
not assessed in Caco-2 cells using the Trypan Blue assay.
BrdU Incorporation assay (DNA synthesis) : Casein and
its hydrolysates exerted different effects on DNA synthe-
sis in Jurkat cells. After 24 h supplementation, casein
hydrolysates a and h, at a level of 0.5% (v/v) only, sig-
nificantly (P<0.05) reduced DNA synthesis to 45.6% and
55.6% (Table 4). Following 24 h treatment of Caco-2
cells with casein hydrolysates, BrdU incorporation was
not affected compared with control (Table 4).
Discussion
There is evidence that milk protein-derived peptides may
have a direct effect on the viability of cancer cells
Table 2. Lactate dehydrogenase (LDH) release from Caco-2 cells incubated with casein hydrolysates (a–h) and sodium caseinate
for 24 h†
Values are the mean± SE for n=3 independent experiments
(% v/v)
LDH release (fold difference)‡
NaCN
Casein hydrolysates
a b c d e f g h
0.0 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06 1.00±0.06
0.5 0.77±0.06 0.83±0.04 0.71±0.06* 0.71±0.07 0.75±0.07 0.81±0.02 0.92±0.15 0.86±0.07 0.98±0.09
1.3 0.78±0.08 0.74±0.07 0.67±0.07* 0.50±0.09* 0.67±0.10 0.73±0.05* 0.69±0.10 0.78±0.02 0.85±0.15
2.5 0.79±0.09 0.82±0.12 0.54±0.11* 0.64±0.11 0.55±0.12* 0.63±0.06* 0.59±0.07 0.72±0.05 0.87±0.19
5.0 0.64±0.08* 0.65±0.06* 0.62±0.04* 0.46±0.07* 0.60±0.09* 0.64±0.08* 0.57±0.10* 0.70±0.09 0.62±0.11
10.0 0.56±0.09* 0.53±0.09* 0.58±0.09* 0.44±0.10* 0.55±0.08* 0.67±0.09* 0.52±0.11* 0.58±0.14* 1.20±0.08
NaCN, sodium caseinate
†Human Caco-2 cells (3r104 cells/cm2) were supplemented with increasing concentrations of casein hydrolysates (a–h) and sodium caseinate for 24 h
‡Cytotoxicity was determined by the LDH release assay. LDH release is expressed as fold difference relative to control
* P<0.05 compared with control (0% v/v) : one-way ANOVA, Dunnett’s test
Table 3. Growth of Caco-2 and Jurkat T cells supplemented with casein hydrolysates (a–h) and sodium caseinate for 24 h†
Values are the mean± SE for n=4 independent experiments
(% v/v)
Cell growth (MTT Reduction index)‡
NaCN
Casein hydrolysates
a b C d e f g h
Caco-2 cells
0.0 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04 0.52±0.04
0.5 0.48±0.03 0.54±0.03 0.50±0.03 0.57±0.04 0.42±0.02 0.40±0.02* 0.59±0.01 0.59±0.01 0.53±0.10
1.3 0.44±0.04 0.46±0.04 0.47±0.05 0.54±0.05 0.39±0.04 0.37±0.02** 0.56±0.01 0.57±0.02 0.48±0.06
2.5 0.46±0.03 0.43±0.01 0.42±0.01 0.41±0.09 0.41±0.04 0.37±0.02** 0.56±0.03 0.53±0.03 0.38±0.02
5.0 0.38±0.03* 0.35±0.03** 0.34±0.02** 0.47±0.02 0.36±0.08 0.36±0.03** 0.57±0.02 0.50±0.02 0.42±0.02
10.0 0.36±0.03** 0.36±0.02** 0.34±0.01** 0.43±0.04 0.44±0.03 0.37±0.03** 0.59±0.02 0.53±0.02 0.43±0.04
Jurkat cells·
0.0 0.71±0.03 0.62±0.04 0.74±0.03 0.70±0.02 0.60±0.05 0.63±0.03 0.60±0.04 0.71±0.02 —
0.5 0.55±0.03** 0.53±0.04 0.43±0.03** 0.57±0.06 0.56±0.06 0.47±0.02** 0.56±0.05 0.67±0.03 —
1.3 0.48±0.03** 0.47±0.03* 0.39±0.02** 0.50±0.04* 0.56±0.04 0.46±0.03** 0.54±0.04 0.63±0.04 —
2.5 0.46±0.03** 0.45±0.03** 0.38±0.03** 0.47±0.04** 0.59±0.03 0.45±0.03** 0.52±0.05 0.62±0.04 —
5.0 0.43±0.03** 0.45±0.03** 0.38±0.03** 0.43±0.03** 0.58±0.04 0.38±0.03** 0.52±0.06 0.60±0.04 —
10.0 0.42±0.03** 0.45±0.04** 0.40±0.03** 0.44±0.04** 0.53±0.05 0.36±0.03** 0.53±0.06 0.60±0.04 —
NaCN, sodium caseinate (which was only available at the time when using Caco-2 cells)
† Cells were supplemented with increasing concentrations of samples for 24 h
·Data that was not shown from a previous study (Phelan et al. 2009)
‡Cell growth was determined by the MTT assay, and expressed as MTT reduction index
* P<0.05, **P<0.01 compared with control : one-way ANOVA, Dunnett’s test
Effects of casein hydrolysates on cancer cell lines 179
(Mac Donald et al. 1994; Hartmann & Meisel, 2004;
Phelan et al. 2009), which offers potential for their in-
clusion into functional foods as these peptides are also of
nutritional importance (Meisel & Schlimme, 1996).
When assessing the therapeutic potential of any novel
sample in vitro, it is important to consider the cell as a
whole and to study the molecular mechanisms underlying
different modulating activities caused by the sample on
individual components within the cell (Gu¨lden & Seibert,
2003). To determine if casein hydrolysates influence the
growth and viability of Jurkat cells and Caco-2 cells, four
different assays were selected, namely the MTT, LDH re-
lease, Trypan Blue, and BrdU incorporation assays.
Both LDH release and Trypan Blue assays are based on
the principle that cell death cascades alter membrane
permeability (Aras et al. 2008). LDH is a soluble cytosolic
enzyme that is released into the culture medium following
loss of membrane integrity, whereas the Trypan Blue assay
measures the ability of cells to exclude dye from being
taken up into their cytoplasm (Aras et al. 2008). The
Trypan Blue assay is very accurate; however it is very
time-consuming when used as a screening assay (Durrieu
et al. 2005). In the Jurkat T cell model there was good
correlation between the results of the LDH release and the
Trypan Blue assays, hence the Trypan Blue assay was not
carried out on the Caco-2 cell model. LDH release was not
negatively affected by the presence of casein hydrolysates
in both the Jurkat cells and Caco-2 cells. Hence, the casein
hydrolysates did not have any major effect on membrane
integrity in these selected cell models.
In the MTT assay, the reduction of MTT by a mito-
chondrial reductase takes place in viable cells when
mitochondrial reductase enzymes are active, which is used
as a measure of mitochondrial activity as well as viability
and growth of cells (Mosmann, 1983). The BrdU incor-
poration assay was selected to analyse DNA synthesis
since this assay is based on the incorporation of BrdU in-
stead of thymidine into DNA during DNA synthesis.
Antibodies specific for BrdU can then be used to detect the
incorporated chemical, thus indicating cells that are ac-
tively replicating their DNA (Motobu et al. 2002).
In Jurkat cells, the MTT and BrdU assays correlated well
as the same trend was seen from both assays. Samples
a and h tended to reduce rates of cell division in Jurkat
cells. This shows that some casein samples have specific
effects on BrdU incorporation during DNA synthesis.
Meisel & Gu¨nther (1998) showed that bioactive sequences
of casein and a lyophilized extract of Gouda cheese had
both apoptotic and anti-proliferative activity in HL-60 cells
at concentrations as low as 1 pmol/l. In addition, Roy et al.
(1999) reported that bovine skimmed milk digested with
the yeast Saccharomyces cerevisiae had an anti-
proliferative activity toward human leukaemia HL-60 cells.
On the other hand, Azuma et al. (1989) found that some
human casein tryptic fragments could stimulate DNA syn-
thesis in BALB/c3T3 cells. MacDonald et al. (1994)
showed that bacterial hydrolysis of casein using commer-
cial yogurt starter cultures yielded bioactive peptides that
reduced [3H]thymidine incorporation in IEC-6 cells and
increased DNA synthesis in Caco-2 cells, thus suggesting
Table 4. Effects of casein hydrolysates (a–h) and sodium caseinate on DNA synthesis in Jurkat cells incubated for 24 h†
Values are the mean±SE for n=4 independent experiments
(% v/v)
DNA synthesis (% control)‡
NaCN
Casein hydrolysates
a b c d e f g h
Caco-2 cells
0.0 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2 100.0±8.2
0.5 101.7±8.3 106.9±8.8 109.6±8.8 93.9±12.0 97.1±9.0 119.0±11.5 110.4±8.0 105.6±9.9 104.9±10.1
1.3 108.4±9.5 95.6±8.7 106.8±8.0 105.4±9.6 108.1±6.0 105.5±9.0 110.0±4.9 115.8±8.8 110.1±7.9
2.5 91.4±13.6 93.6±8.9 89.4±11.5 99.4±8.7 103.5±11.7 103.6±14.8 96.7±12.9 108.2±10.1 93.1±11.5
5.0 109.2±13.7 107.7±12.5 115.1±7.6 114.6±7.4 105.1±12.2 104.4±7.6 105.6±15.4 105.4±12.5 94.9±16.2
10.0 108.7±12.1 78.9±16.4 92.5±6.7 91.3±8.4 106.4±10.4 113.9±12.7 121.3±9.1 103.1±9.4 101.1±5.6
Jurkat cells
0.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0 100.0±16.0
0.5 45.6±3.1* 77.4±6.1 73.0±6.2 85.2±19.9 92.8±14.2 93.6±6.5 72.9±2.2 55.6±0.6* 57.2±2.9
1.3 74.6±10.9 119.7±17.2 106.1±10.7 115.3±9.8 104.8±6.1 106.6±6.5 94.1±5.5 79.3±8.7 101.2±15.7
2.5 79.2±4.5 119.7±4.8 136.3±8.1 125.0±8.3 120.5±3.6 99.6±2.2 94.4±8.0 80.9±9.2 91.9±16.7
5.0 62.1±5.9 111.3±11.8 109.3±11.0 117.8±7.2 104.4±15.3 115.9±2.3 73.7±3.9 64.4±3.8 56.8±2.3
10.0 69.7±9.4 76.5±4.0 112.5±4.4 130.3±1.2 106.5±9.7 85.4±4.6 78.7±21.1 64.6±4.9 76.2±7.3
NaCN, sodium caseinate
†Cells were supplemented with increasing concentrations of casein hydrolysates (a–h) and sodium caseinate for 24 h
‡Cell growth was determined by the BrdU incorporation assay and expressed as a percentage of control (cells)
* P<0.05 compared with control : one-way ANOVA, Dunnett’s test
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cell-specific effects. Furthermore, Ringseis et al. (2005)
showed that certain hydrolysates from casein inhibited
endothelial cell (HaoEC) proliferation whereas other hy-
drolysates had no effect.
Recently, Ramos-Mandujano et al. (2008) showed that
NaCN and its individual casein components displayed
different inhibitory characteristics on the proliferation of
32Dcl3 and WEHI-3 myeloid cells. At 0.1 mg/ml, NaCN
exerted the strongest growth inhibition on 32Dcl3 cells but
the inhibition was not as potent on WEHI-3 cell growth.
This variation in findings may be explained by the different
protein concentrations and the different cell lines used in
these studies (Hagiwara et al. 1995; Ramos-Mandujano
et al. 2008). In addition, the types and sources of peptide
can have individual effects on cells (Hagiwara et al. 1995;
Meisel & Gu¨nther, 1998). In the present study, an expla-
nation for the activity profiles of the hydrolysates may be
that they relate to the different proteolytic enzyme prep-
arations used in their manufacture (manuscript in prep-
aration).
In conclusion, NaCN had no significant effect on the
viability and growth of Caco-2 whereas its associated
casein hydrolysates (a–h) had differing effects on cell vi-
ability and proliferation. Hydrolysate a had an inhibitory
effect on proliferation while e had a promotive effect,
which was cell-specific. The casein hydrolysates seemed
to be more toxic to Jurkat cells compared with Caco-2
cells. A vast majority of tumour promoters are potent in-
hibitors of apoptosis (Wright et al. 1994) and therefore
apoptosis-inducing peptides can be classified as probable
anti-carcinogens. According to Meisel & FitzGerald (2003),
effects on both cell viability and immune function may be
a mechanism by which bioactive peptides exert protective
effects in cancer development. Our data add to our pre-
vious findings and suggest that the eight distinct casein
hydrolysates have varying effects on two different cell
culture models. Further research is warranted to assess the
effects of the casein hydrolysates on the cell cycle of these
two cell lines (Elion, 2001).
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